Natural History of Cervical Neoplasia: Overview and Update
Overview
Authors
Affiliations
Current cervical cancer control strategies and specifically, the screening and treatment policies that have been used during the past 30 years, are based on an understanding of the natural history of cervical neoplasia that does not take into account the important role of human papillomavirus in cervical cancer pathogenesis. This survey presents a review of new data on the causes of cervical cancer and the role of human papillomavirus and recommends the integration of these data. Incorporation of new information on the role of human papillomavirus as the causative agent of most cervical cancers will allow the design of more efficient and more cost-effective strategies for cervical cancer control.
Tempfer C, Schiermeier S, Reinecke J, Ruppenkamp C, Hilal Z Geburtshilfe Frauenheilkd. 2015; 75(10):1051-1057.
PMID: 26556907 PMC: 4629992. DOI: 10.1055/s-0035-1557904.
Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.
Nghiem V, Davies K, Beck J, Follen M, MacAulay C, Guillaud M Br J Cancer. 2015; 112(12):1951-7.
PMID: 25919612 PMC: 4580387. DOI: 10.1038/bjc.2015.95.
Omar T, Schwartz S, Hanrahan C, Modisenyane T, Tshabangu N, Golub J AIDS. 2010; 25(1):87-94.
PMID: 21076276 PMC: 3166782. DOI: 10.1097/QAD.0b013e328340fd99.
Familial cervical cancer: case reports, review and clinical implications.
Zoodsma M, Sijmons R, de Vries E, Van der Zee A Hered Cancer Clin Pract. 2010; 2(2):99-105.
PMID: 20233477 PMC: 2840001. DOI: 10.1186/1897-4287-2-2-99.
Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.
Baak J, Kruse A, Robboy S, Janssen E, van Diermen B, Skaland I J Clin Pathol. 2006; 59(10):1017-28.
PMID: 16679355 PMC: 1861745. DOI: 10.1136/jcp.2005.027839.